HERM Seminar series

13 January

Title: Transitions of oligodendroglia to immune-like states in neuroinflammation and multiple sclerosis: Insights from single-cell and spatial omics

• Speaker: Gonçalo Castelo-Branco, Department of Medical Biochemistry and Biophysics, Karolinska Institutet.
   
• Host: Vanessa Lundin, HERM, MedH, KI.

20 January

Title: Leukemia Immune Escape after Transplantation: From Mechanisms to Precision Medicine Approaches (And Back)

• Speaker: Luca Vago, Associate professor. M.D., Vita-Salute San Raffaele University, Milano, Italy.
   
• Host: Magnus Tobiasson, HERM, MedH, KI.

27 January

Title: Fuelling the CAR; metabolic regulation of therapeutic T cells

• Speaker: Anna Schurich, PhD, Department of Infectious Diseases, School of Immunology and Microbial Sciences, King’s College London, London, UK.
   
• Host: Nicole Marquardt, HERM, MedH, KI.

3 February

Title: Metabolic reprogramming by MYC inhibition as precision medicine in clear cell renal carcinoma and childhood neuroblastoma

• Speaker: Marie Arsenian-Henriksson, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet
   
• Host: Eva Hellström Lindberg, HERM, MedH, KI.

10 February

Title: Tumor immune cell infiltrations driving early tumor progression and therapy response

• Speaker: Carina Strell, Department of Immunology, Genetics and Pathology; Research programme: Cancer Immunotherapy, Uppsala University.
   
• Host: Yenan Bryceson, HERM, MedH, KI.

17 February

Title: Logic-gated Immune Cell Therapy for Cancer

• Speaker: Axel Hyrenius-Wittsten, Lund University's Cancer Centre (LUCC), Lund, Sweden.
   
• Host: William Nyberg, HERM, MedH, KI.

10 March

Title: Learning from the proteins: ontogeny-specific vulnerabilities in fetal- and adult-origin leukemia

• Speaker: Jenny Hansson, Department of Experimental Medical Science, Lund Stem Cell Center, Lund University, Sweden
• Host: Hong Qian, HERM, MedH, KI.

17 March

Title: From Function to Failure: Defining and Combatting HSC Aging

• Speaker: David Bryder, Division of Molecular Hematology (DMH), Lund University.
   
• Host: Stefania Mazzi, HERM, MedH, KI.

24 March

Title: Engineering Microenvironment-Responsive Receptors for Immunotherapy

• Speaker: Leo Scheller, The Leibniz Institute of Immunotherapy (LIT) in Regensburg, Germany.
   
• Host: Yenan Bryceson, HERM, MedH, KI.

31 March

Title: Integrating computational models with experimental systems to study cancer

• Speaker: Dr Xiao Fu, Cancer Research UK, Scotland Institute, University of Glasgow.
   
• Host: Nicole Marquardt and Marco Gerling

7 April

Title: Leveraging single-cell multiomic sequencing to dissect intratumor heterogeneity across AML patients with different cytogenetics

• Speaker: Dr Rachel Thijssen, Amsterdam UMC.
   
• Host: Pedro Moura, HERM, MedH, KI.

14 April

Title: Harnessing NK cells for treatment of highly resistant cancers

• Speaker: Dr. Jiri Eitler, Dresden University of Technology, Germany.
   
• Host: Arnika Wagner, HERM, MedH, KI.

5 May

Title: How is neurotransmitter release triggered in microseconds

• Speaker: Josep Rizo, UTSC.
   
• Host: Yenan Bryceson, HERM, MedH, KI.

12 May

Title: Mapping somatic drivers in hematologic malignancies

• Speaker: Maria Sirenko, Department of Pathology, NYU Grossman School of Medicine, New York, NY USA.
   
• Host: Maria Creignou, HERM, MedH, KI.

19 May

Title: Beyond the Blast Count: Immune Landscapes and New Frontiers in Bone Marrow Failure

• Speaker: Dr Shahram Kordasti, MD, PhD, School of Cancer & Pharmaceutical Sciences, King’s College London, United Kingdom
   
• Host: Magnus Tobiasson, HERM, MedH, KI.

9 June

Title: Transcriptional Programing of T cell immunity to Tumors

• Speaker: Dorina A. Avram, Senior Member and Vice-Chair, Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute and Professor, Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida.
   
• Host: Yenan Bryceson, HERM, MedH, KI.